查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589120

连续血糖监测系统市场：按产品、组件、测试场地、患者照护环境和应用 - 2025-2030 年全球预测

Continuous Blood Glucose Monitoring Systems Market by Product, Component, Testing Site, Patient Care Setting, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

连续血糖监测系统市场2023年估值为45亿美元，预计2024年将达到48.6亿美元，复合年增长率为8.14%，预计到2030年将达到77.9亿美元。

连续血糖监测系统 (CGMS) 是一种动态微创技术，旨在主要为糖尿病患者提供即时血糖浓度评估。对 CGMS 的需求源于全球糖尿病盛行率的不断上升以及改善血糖控制以减少相关健康併发症的迫切需求。 CGMS 的应用范围已从糖尿病患者扩展到运动员和其他寻求最佳血糖管理的注重健康的人。最终使用领域包括医院、诊所和家庭护理场所，促进专业和个人健康监测。市场成长是由技术进步、糖尿病管理意识增强以及医疗保健成本上升所推动的。主要影响因素包括人口老化、可支配收入增加以及适应性健康解决方案的纳入，尤其是在发展中地区。穿戴式科技创新的最新趋势提供了巨大的市场机会。追求技术升级和资料整合协作的公司可以有效地利用这些机会。然而，高成本、不同的报销政策和复杂的监管许可等限制因素正在阻碍成长。新兴市场面临医疗基础设施和意识有限等挑战。创新应侧重于用户易用性、准确性的提高以及人工智慧分析的整合以提供预测性见解，以及无线和非侵入性监控方法。特别是感测器的更长寿命和小型化等研究方法可能会导致业务扩张。这个市场充满活力、竞争激烈，并且在个人化健康监测的迫切需求的推动下，有望实现变革性成长。公司需要专注于研发投资、满足监管标准以及策略伙伴关係，以充分利用市场潜力。专注于教育宣传活动、优化成本结构和扩大低成本设备的可用性可以进一步缓解当前的障碍并提高市场渗透率。

主要市场统计
基准年[2023] 45亿美元
预测年份 [2024] 48.6亿美元
预测年份 [2030] 77.9亿美元
复合年增长率（%） 8.14%

市场动态：快速发展的连续血糖监测系统市场的关键市场洞察

供应和需求的动态交互作用正在改变连续血糖监测系统市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 随着糖尿病患者数量的增加，需要有效的方法来检测血糖值的快速变化
    • 连续血糖监测系统与 POC 血糖仪相比的优势
    • 透过政府主导提高产品知名度
  • 市场限制因素
    • 与测量精度和准确度以及感测器寿命相关的成本
  • 市场机会
    • 家庭医疗保健中连续血糖监测系统的采用率提高
    • 潜在的未确诊患者群体
  • 市场挑战
    • 模式不稳定性和结果的可重复性

波特五力：引领连续血糖监测系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解连续血糖监测系统市场的外部影响

外部宏观环境因素在塑造连续血糖监测系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解连续血糖监测系统市场的竞争格局

对连续血糖监测系统市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵连续血糖监测系统市场供应商的绩效评估

FPNV 定位矩阵是评估连续血糖监测系统市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了连续血糖监测系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对连续血糖监测系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着糖尿病患者数量的增加，需要一种有效检测血糖值快速变化的方法。
      • 与照护现场血糖仪相比，连续血糖监测系统的优势
      • 透过政府措施提高产品知名度
    • 抑制因素
      • 与测量准确度和精度以及感测器寿命相关的成本
    • 机会
      • 提高连续血糖监测系统在家庭医疗保健中的采用率
      • 潜在的未确诊患者群体
    • 任务
      • 模式不稳定性和结果的可重复性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章连续血糖监测系统市场：副产品

  • 连续血糖监测系统
    • 接收器
    • 感应器
    • 发送器
  • 自我血糖测量系统
    • 血糖值仪
    • 采血针和采血装置
    • 试纸

第七章连续血糖监测系统市场：依组成部分

  • 动态监测仪
  • 连续监测发射机
  • 葡萄糖感测器

第八章连续血糖监测系统市场（依测试地点）

  • 替代站点测试
  • 指尖测试

第九章按患者照护环境分類的连续血糖监测系统市场

  • 医院/诊所
  • 自我护理或居家护理

第10章连续血糖监测系统市场：依应用分类

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第十一章美洲连续血糖监测系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太连续血糖监测系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲连续血糖监测系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • A. Menarini Diagnostics srl
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlySens Incorporated
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holdings, LLC
  • Medtronic PLC
  • Novo Nordisk A/S
  • OrSense Ltd.
  • PHC Holdings Corporation
  • Senseonics Holdings, Inc.
  • Tandem Diabetes Care, Inc.
Product Code: MRR-433AB1DC2935

The Continuous Blood Glucose Monitoring Systems Market was valued at USD 4.50 billion in 2023, expected to reach USD 4.86 billion in 2024, and is projected to grow at a CAGR of 8.14%, to USD 7.79 billion by 2030.

Continuous Blood Glucose Monitoring Systems (CGMS) are dynamic, minimally invasive technologies designed to provide real-time glucose level assessments, primarily for diabetic patients. The necessity for CGMS arises from the growing global diabetes prevalence and the urgent need for better glycemic control to reduce associated health complications. Its applications extend beyond diabetic patients to include athletes and other health-conscious individuals seeking optimal glucose management. End-use sectors include hospitals, clinics, and homecare settings, facilitating both professional and personal health monitoring. Market growth is driven by technological advancements, heightened awareness regarding diabetes management, and rising health expenditures. Key influencing factors include an aging population and increased disposable incomes, particularly in developing regions embedding adaptive health solutions. Recent trends unveiling wearable technology innovations offer significant market opportunities. Companies pursuing collaborations for tech upgrades and data integration can leverage these opportunities effectively. However, limitations such as high costs, varying reimbursement policies, and the complexity of regulatory clearances hinder growth. Emerging markets face challenges like limited healthcare infrastructure and awareness. Innovation should focus on enhancing user ease, accuracy, and integrating AI analytics to offer predictive insights, as well as wireless and non-invasive monitoring methods. Research avenues, particularly in improving sensor longevity and reducing size, will likely lead to business expansion. This market is dynamic, highly competitive, and poised for transformative growth, driven by an urgent demand for personalized health monitoring. Companies need to invest in R&D, align with regulatory standards, and focus on strategic partnerships to harness market potential. Emphasizing education campaigns, optimizing cost structures, and expanding low-cost device availability will further mitigate current barriers and bolster market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 4.50 billion
Estimated Year [2024] USD 4.86 billion
Forecast Year [2030] USD 7.79 billion
CAGR (%) 8.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Blood Glucose Monitoring Systems Market

The Continuous Blood Glucose Monitoring Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
    • Benefits associated with continuous blood glucose monitoring systems over Point-of-Care glucometers
    • Increasing awareness through government initiatives for the product
  • Market Restraints
    • Accuracy and precision on measurement and cost associated with sensor lifetime
  • Market Opportunities
    • Growing adoption rate of continuous blood glucose monitoring systems in home healthcare
    • Potential undiagnosed patient population
  • Market Challenges
    • Instability of patterns and reproducibility to results

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Blood Glucose Monitoring Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Blood Glucose Monitoring Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Blood Glucose Monitoring Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Blood Glucose Monitoring Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Blood Glucose Monitoring Systems Market

A detailed market share analysis in the Continuous Blood Glucose Monitoring Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Blood Glucose Monitoring Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Blood Glucose Monitoring Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Continuous Blood Glucose Monitoring Systems Market

A strategic analysis of the Continuous Blood Glucose Monitoring Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Continuous Blood Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, B. Braun Melsungen AG, Dexcom, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlySens Incorporated, Johnson & Johnson Services, Inc., LifeScan IP Holdings, LLC, Medtronic PLC, Novo Nordisk A/S, OrSense Ltd., PHC Holdings Corporation, Senseonics Holdings, Inc., and Tandem Diabetes Care, Inc..

Market Segmentation & Coverage

This research report categorizes the Continuous Blood Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Continuous Glucose Monitoring Systems and Self-Monitoring Blood Glucose Systems. The Continuous Glucose Monitoring Systems is further studied across Receivers, Sensors, and Transmitters. The Self-Monitoring Blood Glucose Systems is further studied across Blood Glucose Meters, Lancets & Lancing Devices, and Testing strips.
  • Based on Component, market is studied across CGM Monitor, CGM Transmitter, and Glucose Sensor.
  • Based on Testing Site, market is studied across Alternate Site Testing and Fingertip Testing.
  • Based on Patient Care Setting, market is studied across Hospital & Clinics and Self or Home Care.
  • Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
      • 5.1.1.2. Benefits associated with continuous blood glucose monitoring systems over Point-of-Care glucometers
      • 5.1.1.3. Increasing awareness through government initiatives for the product
    • 5.1.2. Restraints
      • 5.1.2.1. Accuracy and precision on measurement and cost associated with sensor lifetime
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption rate of continuous blood glucose monitoring systems in home healthcare
      • 5.1.3.2. Potential undiagnosed patient population
    • 5.1.4. Challenges
      • 5.1.4.1. Instability of patterns and reproducibility to results
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Continuous Blood Glucose Monitoring Systems Market, by Product

  • 6.1. Introduction
  • 6.2. Continuous Glucose Monitoring Systems
    • 6.2.1. Receivers
    • 6.2.2. Sensors
    • 6.2.3. Transmitters
  • 6.3. Self-Monitoring Blood Glucose Systems
    • 6.3.1. Blood Glucose Meters
    • 6.3.2. Lancets & Lancing Devices
    • 6.3.3. Testing strips

7. Continuous Blood Glucose Monitoring Systems Market, by Component

  • 7.1. Introduction
  • 7.2. CGM Monitor
  • 7.3. CGM Transmitter
  • 7.4. Glucose Sensor

8. Continuous Blood Glucose Monitoring Systems Market, by Testing Site

  • 8.1. Introduction
  • 8.2. Alternate Site Testing
  • 8.3. Fingertip Testing

9. Continuous Blood Glucose Monitoring Systems Market, by Patient Care Setting

  • 9.1. Introduction
  • 9.2. Hospital & Clinics
  • 9.3. Self or Home Care

10. Continuous Blood Glucose Monitoring Systems Market, by Application

  • 10.1. Introduction
  • 10.2. Gestational Diabetes
  • 10.3. Type 1 Diabetes
  • 10.4. Type 2 Diabetes

11. Americas Continuous Blood Glucose Monitoring Systems Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Blood Glucose Monitoring Systems Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A. Menarini Diagnostics s.r.l.
  • 2. Abbott Laboratories
  • 3. B. Braun Melsungen AG
  • 4. Dexcom, Inc.
  • 5. Eli Lilly and Company
  • 6. F. Hoffmann-La Roche AG
  • 7. GlySens Incorporated
  • 8. Johnson & Johnson Services, Inc.
  • 9. LifeScan IP Holdings, LLC
  • 10. Medtronic PLC
  • 11. Novo Nordisk A/S
  • 12. OrSense Ltd.
  • 13. PHC Holdings Corporation
  • 14. Senseonics Holdings, Inc.
  • 15. Tandem Diabetes Care, Inc.

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LANCETS & LANCING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM TRANSMITTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GLUCOSE SENSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ALTERNATE SITE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY FINGERTIP TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF OR HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY